tenk.fyi

ACHIEVE LIFE SCIENCES, INC.

ACHVNasdaq· In Vitro & In Vivo Diagnostic Substances

Price History

Revenue

-

Net Income

-$54.6M

37.2% YoY

EPS

$-1.25

0.8% YoY

Cash

$20.9M

64.1% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro